Saturday, July 11, 2026

Drug profile · INN

vinblastine

vinblastine (DBL VINBLASTINE) is a tubulin inhibitor. Associated with Pfizer Australia Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — vinblastine

Quick answer

vinblastine (DBL VINBLASTINE) is a tubulin inhibitor. Associated with Pfizer Australia Pty Ltd.

Key facts

INN vinblastine
Brand DBL VINBLASTINE
Mechanism Tubulin inhibitor

Mechanism of action

Tubulin inhibitor

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. 042011 Phase 3 · George Institute for · Langerhans Cell Histiocytosis
  2. C25003 Phase 3 · Takeda · Advanced Classical Hodgkin Lymphoma
  3. DAY101-002 Phase 3 · Anaxis Pharma · Pediatric low-grade glioma harboring an activating RAF alter
  4. 1537-LYMG Phase 2 · Ningbo Cancer Hospital · Advanced stage Hodgkin Lymphoma
  5. MK-3475-667 Phase 2 · MSD Merck Sharp · Classical Hodgkin lymphoma in children and young adults

Frequently asked questions

What is vinblastine?

vinblastine (DBL VINBLASTINE) is a tubulin inhibitor. Associated with Pfizer Australia Pty Ltd.

What is the brand name for vinblastine?

DBL VINBLASTINE is a marketed brand name for vinblastine. Check FDA Drugs@FDA for the current US label holder and prescribing information.